Gen Surg Cases · vascular
Febrile tunneled catheter with prior ipsilateral line — lock, exchange, culture, and contralateral planning
Fellowship clinical-management station on catheter-related bacteremia with clean tunnel and ipsilateral catheter history: exchange-ladder decision with cure arithmetic, lock prophylaxis numbers, bacteremia risk counselling, and contralateral permanent-access planning with distal-first configuration.
On this page
Study tools
Target exams
Expected management
Exchange by appearance, not by reflex. Minimal symptoms with a clean tunnel and no tunnel tenderness earn guidewire exchange within 48 hours of antibiotic initiation with 87.8% cure — against 75% for new-tunnel exchange where tunnel infection exists and 86.5% for removal with delayed replacement in severe sepsis — all followed by 3 weeks of culture-directed antibiotics to a 45-day symptom-free cure definition.[54] Quote the bacteremia context aloud: 1-year risk 9% with 30/38% any-complication at 1/2 years in Canadians, 0.40 per 1000 days over 14 years with 8.7% 30-day mortality from the first episode — so the febrile catheter earns cultures before antibiotics and urgency before reassurance.[49][50]
Lock the next catheter by evidence. Minocycline-EDTA beats heparin at 1.1 against 4.3 per 1000 days with superior bacteremia-free survival — gentamicin-citrate beats heparin at 0.45 against 1.68 for a 73% adjusted cut — while femoral placement with diabetes and vintage predicts infection with HbA1c 9.350 as the diabetic threshold — so the replacement line goes jugular, locked by trial, with the catheter career shortened toward permanent access.[52][53][51]
Plan permanent access contralateral and distal-first. Ipsilateral catheter history leaves primary failure unchanged but more than doubles the cumulative fistula hazard at 2.48 — so the fistula goes contralateral, radiocephalic first despite brachiocephalic flow advantages (492 vs 307 mL/min, patency 88.7 vs 62.9%), with plexus block lifting 3-month patency (OR 3.3) — and maturation consented at 36.2% never-used nationally with small-vein predictors named.[55][23][59][18][16]
Close with surveillance and cannulation. Flow surveillance with preemptive repair halves fistula thrombosis and loss (RR 0.5 each) with repair above 500 mL/min tripling benefit — rope-ladder needling as the in-centre default with buttonhole infection at 2.6-fold disclosed — and KDOQI Life-Planning framing the whole sequence.[38][44][45][47][57]
References16ShowHide
- [54]Beathard GA Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol, 1999.PMID 10232691
- [49]Poinen K, et al. Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study. Am J Kidney Dis, 2019.PMID 30642607
- [50]Almenara-Tejederas M, et al. Tunneled catheter-related bacteremia in hemodialysis patients: incidence, risk factors and outcomes. A 14-year observational study. J Nephrol, 2023.PMID 35976569
- [52]Campos RP, et al. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol, 2011.PMID 21852579
- [53]Moore CL, et al. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Clin J Am Soc Nephrol, 2014.PMID 24970874
- [51]Arslan M, et al. Tunneled Catheter-Related Bloodstream Infections in Chronic Hemodialysis Patients: Frequency, Risk Factors, and Outcomes-A 10-Year Analysis. APMIS, 2025.PMID 40078110
- [55]Shingarev R, et al. Association of hemodialysis central venous catheter use with ipsilateral arteriovenous vascular access survival. Am J Kidney Dis, 2012.PMID 22824354
- [23]Ryu YG, et al. Outcomes of Autogenous Radiocephalic Versus Brachiocephalic Arteriovenous Fistula Surgery Based on Transit-Time Flowmeter Assessment: A Retrospective Study. Ann Vasc Surg, 2022.PMID 34936890
- [59]Aitken E, et al. Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial. Lancet, 2016.PMID 27492881
- [18]Woodside KJ, et al. Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study. Am J Kidney Dis, 2018.PMID 29429750
- [16]Feldman HI, et al. Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis, 2003.PMID 14582044
- [38]Ravani P, et al. Pre-emptive correction for haemodialysis arteriovenous access stenosis. Cochrane Database Syst Rev, 2016.PMID 26741512
- [44]Tessitore N, et al. Pro: Vascular access surveillance in mature fistulas: is it worthwhile? Nephrol Dial Transplant, 2019.PMID 30768204
- [45]Wong B, et al. Buttonhole versus rope-ladder cannulation of arteriovenous fistulas for hemodialysis: a systematic review. Am J Kidney Dis, 2014.PMID 25110302
- [47]Lyman M, et al. Risk of Vascular Access Infection Associated With Buttonhole Cannulation of Fistulas: Data From the National Healthcare Safety Network. Am J Kidney Dis, 2020.PMID 32151430
- [57]Lok CE, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis, 2020.PMID 32778223